Is low‐dose glucagon needed and effective in preventing fasted exercise‐induced hypoglycaemia in type 1 diabetes treated with the MiniMed 780G , an automated insulin delivery system?
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Sissel Banner Lundemose und 7 weiteren Autor:innen. Beteiligte Einrichtung: Steno Diabetes Center Copenhagen, Clinical and Translational Research, Diabetes Technology Research, Herlev, Denmark. Hauptthemen laut MEDLINE: Glucagon, Diabetes Mellitus, Type 1, Hypoglycemia, Exercise. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
To evaluate and compare the plasma glucose (PG) response during spontaneous fasted morning moderate‐intensity exercise with and without injection of subcutaneous glucagon in adults with type 1 diabetes (T1D) treated with an automated insulin delivery (AID) system.
Methods
Ten adults (four female) with T1D (age 50 [42–67] years, diabetes duration: 22 [14–44] years, HbA1c: 55 [47–69] mmol/mol) treated with the MiniMed™ 780G AID system participated in a proof‐of‐concept two‐period, crossover trial. Fasting participants undertook a 45 min bout of continuous moderate‐intensity (~60% V̇O 2peak ) exercise on a cycle ergometer followed by 1 h of rest. Before exercise, 150‐μg glucagon was administered subcutaneously on visit 1 (GLUC) but not on visit 2 (NO‐GLUC). Temporary target on the AID was activated 15 min before until 15 min after exercise cessation. Blood samples were taken at 5‐ and 15‐min intervals for measuring PG and biomarkers. Data were analysed using paired t tests or repeated measures ANOVA.
Results
Time in range (3.9–10.0 mmol/L) was 100% on both study visits. No hypoglycaemia (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Steno Diabetes Center Copenhagen, Clinical and Translational Research, Diabetes Technology Research, Herlev, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Applied Sport, Technology, Exercise and Medicine Research Centre, Swansea University, Swansea, UK.
- Health Technology and Solutions Interdisciplinary Research Institute, Faculty of Science and Engineering, Swansea University, Swansea, UK.
- Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Sissel Banner Lundemose, Christian Laugesen, Richard M Bracken, Jens Juul Holst, Ajenthen Gayathri Ranjan
Zitieren
APA
Lundemose, S. B., McCarthy, O. M., Christensen, M. B., Laugesen, C., Bracken, R. M., Holst, J. J., Ranjan, A. G., & Nørgaard, K. (2025). Is low‐dose glucagon needed and effective in preventing fasted exercise‐induced hypoglycaemia in type 1 diabetes treated with the MiniMed 780G , an automated insulin delivery system?. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16103
Vancouver
Lundemose SB, McCarthy OM, Christensen MB, Laugesen C, Bracken RM, Holst JJ, et al. Is low‐dose glucagon needed and effective in preventing fasted exercise‐induced hypoglycaemia in type 1 diabetes treated with the MiniMed 780G , an automated insulin delivery system?. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16103
BibTeX
@article{Lundemose2025,
author = {Lundemose, Sissel Banner and McCarthy, Olivia M and Christensen, Merete Bechmann and Laugesen, Christian and Bracken, Richard M and Holst, Jens Juul and Ranjan, Ajenthen Gayathri and Nørgaard, Kirsten},
title = {Is low‐dose glucagon needed and effective in preventing fasted exercise‐induced hypoglycaemia in type 1 diabetes treated with the MiniMed 780G , an automated insulin delivery system?},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16103}
}
EUVIMED